Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michael Untch"'
Autor:
Bertram Glass, Daniel Amrein, Annette Reichardt, Sven Hohenstein, Peter Reichardt, Ralf Kuhlen, Andreas Bollmann, Michael Untch
Publikováno v:
Oncology Research and Treatment
Background: The COVID-19 pandemic lead to a massive shutdown of social life in Germany starting in March 2020. Elective medical treatment was substantially reduced but urgent diagnostics and treatment including cancer care should not have been affect
Autor:
Sibylle Loibl, Gunter von Minckwitz, Michael Untch, Carsten Denkert, C. on behalf of the German Breast Group
Publikováno v:
Oncology Research and Treatment. 37:563-568
SummaryWithin 2 decades, neoadjuvant therapy (NAT) has become a standard treatment option in breast cancer. The advantage of NAT is the ability to monitor the treatment effect. Pathological complete response (pCR) after NAT is a very good predictor f
Autor:
Anton Scharl, Elmar Stickeler, Thomas Papathemelis, Annette Salterberg, Michael Untch, Cornelia Liedtke
Publikováno v:
Oncology research and treatment. 39(3)
Patients not older than 40 years are referred to as young patients. These women benefit from chemo-, endocrine and anti-HER2 therapy to a similar degree as older women. Surgery and radiation therapy also follow the same recommendations. This manuscri
Management of Cytotoxic Extravasation - ASORS Expert Opinion for Diagnosis, Prevention and Treatment
Autor:
Regine Mayer-Steinacker, Hans-Peter Lipp, Maike de Wit, Carsten Bokemeyer, Markus Ruhnke, Karin Jordan, Jalid Sehouli, Petra Ortner, Michael Untch
Publikováno v:
Oncology Research and Treatment. 36:127-135
Background: Cytotoxic extravasation is a rare but potentially serious and painful complication of intravenous drug administration in oncology. Literature is anecdotal, and systematic clinical trials are scarce. The German working group for Supportive
Publikováno v:
Oncology research and treatment. 39(3)
Intrinsic subtypes based on gene expression have substantially improved the understanding of the biological diversity and heterogeneity of breast cancer. The efficacy of adjuvant therapies depends on the level of risk for an individual patient. Becau
Autor:
Steffen Kahlert, Hans-Joachim Stemmler, Michael Untch, Bernhard Heinrich, Wolfgang Siekiera, Volker Heinemann
Publikováno v:
Oncology Research and Treatment. 28:582-586
Background: The aim of this retrospective analysis was to evaluate the impact of trastuzumab-based regimens on the survival of patients with HER2-overexpressing metastatic breast cancer (MBC). The study specifically focussed on the influence of the c
Autor:
Rainer Linke, K. Hahn, M. Keßler, Michael Untch, Harald Sommer, Reinhold Tiling, K. Brinkbäumer
Publikováno v:
Oncology Research and Treatment. 26:27-31
Background: Aim of the study was to assess the value of scintimammography using Tc-99m sestamibi in the evaluation of tumor response to neoadjuvant chemotherapy. Material and Methods: Results were calculated for 9 patients undergoing neoadjuvant chem
Autor:
H. Eidtmann, G. von Minckwitz, Fritz Jänicke, Michael Untch, Nadia Harbeck, Annette Lebeau, G. Schaller, C. Thomssen, A. H. Tulusan, H. Meden
Publikováno v:
Oncology Research and Treatment. 25:I-IV
Autor:
C. Thomssen, G. Schaller, Michael Untch, H. Eidtmann, Nadia Harbeck, Fritz Jänicke, H. Meden, G. von Minckwitz, Annette Lebeau, A. H. Tulusan
Publikováno v:
Oncology Research and Treatment. 25:1-28
Autor:
Rolf Kreienberg, Werner Meier, A. du Bois, Michael Untch, Steffen Kahlert, Alexander Burges, Walther Kuhn, Werner Lichtenegger, C. Thomssen, Thomas Bauknecht, J. Schüller, Fritz Jänicke, Jacobus Pfisterer, Volker Möbus, C. Crohns, M. Gropp, H. Hepp
Publikováno v:
Oncology Research and Treatment. 23:I-IV